Dow Chemical Company’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Dow Chemical Company’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-50,000	Closed	-$414K	–	121
2015 Q2	$414K	Hold	50,000	–	–	0.04%	100
2015 Q1	$412K	Hold	50,000	–	–	0.04%	91
2014 Q4	$344K	Sell	50,000 -20,000	-29%	-$125K	0.03%	83
2014 Q3	$378K	Sell	70,000 -90,000	-56%	-$526K	0.03%	89
2014 Q2	$1.02M	Buy	160,000 +35,000	+28%	+$241K	0.09%	73
2014 Q1	$1.01M	Buy	125,000 +90,000	+257%	+$701K	0.08%	75
2013 Q4	$239K	Buy	+35,000	New	+$189K	0.02%	73

Other funds holding ARIA

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Dow Chemical Company's ARIA Position: Q3 2015 in Review

Dow Chemical Company sold out of Ariad Pharmaceuticals Inc (ARIA) in Q3 2015, closing a stake of 50,000 shares — an estimated $414K sold.

Dow Chemical Company first reported a position in ARIA in Q4 2013 and held it in 7 quarters. The position peaked at $1.02M in Q2 2014. 175 funds tracked by Wall St. Rank hold ARIA as of Q3 2015.

Dow Chemical Company reported no remaining Ariad Pharmaceuticals Inc position as of Q3 2015 after selling out during the quarter.
Dow Chemical Company sold 50,000 Ariad Pharmaceuticals Inc shares in Q3 2015, an estimated $414K.
Dow Chemical Company first reported a position in Ariad Pharmaceuticals Inc in Q4 2013 and held it in 7 quarters.
Dow Chemical Company's Ariad Pharmaceuticals Inc position peaked at $1.02M in Q2 2014.
175 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q3 2015.

Based on Dow Chemical Company's 13F filing for Q3 2015, filed 13 Nov 2015.